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INTRODUCTION
MHC class II molecules are transmembrane proteins
present at the plasma membrane. They consist of polymor-
phic a and b chains, which are involved in the presenta-
tion of peptides, derived from exogenous antigens, to T
helper cells (Unanue, 1984). Antigens are thought to be
taken up by endocytosis, proteolytically processed and then
bound to class II molecules in the endocytic pathway (Long
and Jacobson, 1989; Koch et al., 1989).
Class II molecules assemble in the endoplasmic reticu-
lum with a third polypeptide, the invariant chain (Ii) (Jones
et al., 1978; Kvist et al., 1982), and are then transported to
the endocytic pathway where Ii is proteolytically processed
and dissociated from the class II molecules (Neefjes et al.,
1990; Pieters et al., 1991). The major form of Ii (P33) is a
type II transmembrane protein of 216 amino acid residues
of which the 30 N-terminal residues are cytoplasmically
exposed. In man, a 35 kDa form of Ii (P35), with a 15
amino acid residue extension at the N terminus is present,
which results from initiation of translation at an AUG codon
upstream of that used to generate the major translation form
(O’Sullivan et al., 1987; Strubin et al., 1986). This N-ter-
minal extension has been found to be responsible for retain-
ing Ii in the endoplasmic reticulum (Lotteau et al., 1990).
Both in mice and man an additional form of Ii (P41) arises
through the use of an alternatively spliced exon (Strubin et
al., 1986; Koch et al., 1987).
Ii ha  been proposed to perform two functions (Long and
Jacobson, 1989; Koch et al., 1989). First, it prevents class
II mol cules from binding peptides prematurely in the ER
(Roche and Cresswell, 1990; Teyton et al., 1990). Second,
Ii targets the MHC class II complex to endosomes (Bakke
and Dobberstein, 1990; Lotteau et al., 1990).
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The oligomeric complex formed by major histocompat-
ibility complex (MHC) class II and chains and
invariant chain (Ii) assembles in the endoplasmic retic-
ulum and is then transported via the Golgi complex to
compartments of the endocytic pathway. When Ii alone
is expressed in CV1 cells it is sorted to endosomes. The
Ii cytoplasmic tail has been found to be essential for tar-
geting to these compartments. In order to characterize
further the signals responsible for endosomal targeting,
we have deleted various segments of the cytoplasmic tail.
The Ii mutants were transiently expressed and the cel-
lular location of the proteins was analyzed biochemi-
cally and morphologically. The cytoplasmic tail of Ii was
found to contain two endosomal targeting sequences
within its cytoplasmic tail; one targeting sequence was
present within amino acid residues 12-29 and deletion
of this segment revealed the presence of a second endo-
somal targeting sequence, located within the Þrst 11
amino acid residues. The presence of a leucine-isoleucine
pair at positions 7 and 8 within this sequence was found
to be essential for endosomal targeting.
In addition, the presence of this L-I motif lead to accu-
mulation of Ii molecules in large endosomal vacuoles
containing lysosomal marker proteins. Both wild type Ii
and Ii mutant molecules containing only one endosomal
targeting sequence were rapidly internalized from the
plasma membrane.
When the Ii cytoplasmic tail was fused to the mem-
brane-spanning region of neuraminidase, a resident
plasma membrane protein, the resulting chimera (INA)
was found in endocytic compartments containing lyso-
somal marker proteins. Thus the cytoplasmic tail of Ii
is sufficient for targeting to the endocytic/lysosomal
pathway.
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When the 33 kDa form of human Ii, P33, is expressed
in CV1 cells in the absence of MHC class II molecules, it
is found in organelles of the endocytic pathway. Very little
Ii can be detected at the plasma membrane. Mutant Ii pro-
teins from which 15 or more N-terminal amino acid
residues are deleted accumulate at the plasma membrane
when expressed in CV1 cells (Bakke and Dobberstein,
1990). In HeLa cells, expression of Ii mutant proteins from
which the 29 N-terminal amino acid residues are deleted
accumulate at the plasma membrane. From these findings
it has been concluded that the cytoplasmic tail of Ii con-
tains targeting information for the endocytic pathway
(Bakke and Dobberstein, 1990; Lotteau et al., 1990).
The pathway by which Ii reaches endosomal compart-
ments, when expressed in the absence of MHC class II mol-
ecules, is not known. Ii could follow the secretory route to
the plasma membrane, and then be internalized into the
endocytic pathway. Alternatively, Ii could be delivered
directly from the trans-Golgi network (TGN) to the endo-
somes. Finally, it has been proposed that Ii may follow a
route to endosomes bypassing the Golgi complex. This was
concluded from the incomplete terminal glycosylation of Ii
and its presence in endosomal/lysosomal structures (Lot-
teau et al., 1990). 
Proteins that are known to be internalized from the
plasma membrane, such as the LDL receptor (Goldstein et
al., 1985), transferrin receptor (Collawn et al., 1990;
Ktikakis et al., 1990) and the epidermal growth factor
receptor (Prywes et al., 1986) contain a cytoplasmically
located aromatic residue within a sequence that adopts a
tight turn conformation (Bansal and Gierasch, 1991; Eberle
et al., 1991). Ii does not contain any aromatic amino acid
residue in its cytoplasmic tail.
Recently a second type of endosomal targeting signal has
been identified. This signal centers around a di-leucine or
a leucine-isoleucine motif (Letourneur and Klausner, 1992,
Johnson and Kornfeld, 1992). This motif was shown to be
responsible for endocytosis when transplanted onto the Tac
antigen (Letourneur and Klausner, 1992). The cytoplasmic
tail of the (cation-independent) mannose 6-phosphate recep-
tor (CI-MPR) also contains a leucine-leucine pair that is
involved in efficient Golgi sorting to the endosomal/lyso-
somal pathway (Johnson and Kornfeld, 1992).
The cytoplasmic tail of Ii can be replaced by that of
b -1,4-galactosyltransferase (GT), a trans-Golgi resident
enzyme (Nilsson et al., 1991) without affecting the final
location. The GT cytoplasmic tail contains a di-leucine
motif implicated in endocytosis function. GT appears to
contain at least two signals, one within the transmembrane
segment that specifies location in ra s-Golgi cisternae, and
one in the cytoplasmic tail that retrieves GT from the
plasma membrane.
To define more precisely the signals responsible for Ii
targeting to and retention in endosomes, we deleted seg-
ments of the Ii cytoplasmic tail and determined the cellu-
lar location of the resulting mutant proteins. We found that
two endosomal targeting signals are present within the Ii
cytoplasmic tail, each of which, separately, was sufficient
for endosomal targeting. Furthermore, Ii mutants that con-
tained the first endosomal targeting signal, which we show
is a leucine-isoleucine pair, accumulated in large endoso-
mal vacuoles. 
To investigate whether the Ii cytoplasmic tail is suffi-
cient to target a passenger protein to endosomes, we fused
the invariant chain cytoplasmic tail to the transmembrane
and luminal domain of influenza neuraminidase (NA), a res-
ident plasma membrane molecule. We show that the Ii cyto-
plasmic tail was sufficient for targeting to the
endocytic/lysosomal pathway. However, no accumulation
of the chimeric INA molecule in large vacuoles was
observed. This suggests that sequences either within the
transmembrane and/or luminal domain of Ii also contribute
to the precise endosomal location of Ii.
MATERIALS AND METHODS
Plasmid constructions
D 12-15IipSV51L
D 12-15IipSV51L was constructed by amplifying a fragment in the
5¢ region of the coding sequence of the human Ii using the poly-
merase chain reaction (PCR) and D C12IiCAT as a template (Lipp
and Dobberstein, 1988). One of the primers that was used in the
PCR reaction was identical to the coding bases 1-18 of Ii, and
was extended at the 5¢ nd to introduce NcoI, SmaI and XmaI
sites (primer 1; 5¢ -CGCGCCCGGGCCATGGATGACCAGCGC-
GAC-3¢ ). The second primer was complementary to coding bases
12-61, excluding bases 34-45 (coding for amino acids E12QLP15),
and was extended at the 5¢ end with a G+C-rich sequence
( 5¢ -G C G C G G C G C C G G C C C A G C A T A T T G T T G G A G A T A A G -
GTCGCC-3¢ ). The amplified fragment was digested with XmaI
and NarI and ligated into plasmid IipSV51L (Bakke and Dob-
berstein, 1990), which had been digested with the same enzymes.
D 21-29IipSV51L
D 21-29IipSV51L was constructed using a similar strategy as was
used for D 12-15IipSV51l, except that the second primer was com-
plementary to coding bases 43-61 (coding for amino acids
P15MLGRR20) of Ii, and contained a SacII site at the 5¢ end (5¢ -
GCGGCCGCGGCGCCGGCCCAGCATGGG-3¢ ). The amplified
fragment was then digested with XmaI and SacII and ligated into
IipSV51L, which had been digested with the same enzymes.
D 13IipSV51L
D 13IipSV51L was constructed using IipSV51L as a template for
PCR. Primer 1 was as described above. The second primer coded
for amino acids S9-R20excluding Q13 (5¢ -GCGCGGCGCCGGC-
CCAGCATGGGCAGCTCATTGTTGGA-3¢ ). The amplified frag-
ment was digested with XmaI and NarI, and ligated into IipSV51L
that was digested with the same enzymes.
D 16-29IipSV51L
D 16-29IipSV51L was constructed by amplifying a fragment using
D 21-29IipSV51L as a template and primer 1. The second primer
was complementary to coding bases 26-50 of D 21-29Ii, exclud-
ing bases 46-54 (coding for M16LG18; 5¢ -GGGCTCCGCG-
GCGCCGGGGCAGTTGCTCATTGTTGG-3¢ ). The amplified
fragment was digested with XmaI and SacII and ligated into
IipSV51L digested with the same enzymes.
D 12-29IipSV51L
The co struction of D 12-29IipSV51L was similar to that of D 16-
29IipSV51L, except that as a second primer an oligonucleotide
was used complementary to coding bases 13-70 of D 21-29Ii,
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excluding bases 34-54 (coding for E12QLPMLG18; 5¢ -GGGCTC-
CGCGGCGCCGATTGTTGGAGATAAGGTCGCG-3¢ ). The re-
sulting fragment was digested with XmaI and SacII and ligated
into IipSV51L digested with the same enzymes.
D 12-29IipSV51LLI-AA
This construct was made from D 12-29IipSV51L by exchanging a
XmaI-SacII fragment for two annealed oligos encoding the first
11 amino acids of Ii with the leucine and isoleucine at positions
7 and 8 changed to alanine.
NApSV51L
The cDNA for neuraminidase from human influenza virus strain
A7/Victoria/3/75 (van Rompuy et al., 1982) was excised from
pSV23NA (Huylebroeck et al., 1988) as a HindIII fragment,
blunted by DNA polymerase I and ligated into the SmaI sit  of
pSV51L.
INApSV51L
A SacII site was introduced at the cytoplasmic side of the trans-
membrane region of neuraminidase and a BamHI site was intro-
duced downstream of the neuraminidase coding region by PCR
with two primers that introduced these two sites. The SacII-BamHI
fragment was isolated and ligated into IipSV51L that was digested
with the same enzymes. 
The constructs D 1-11Ii and D 1-15Ii have been described previ-
ously as D 11Ii and D 15Ii (Bakke and Dobberstein, 1990). All con-
structs were verified in the mutated region by sequencing as
described by Sanger (Sanger et al., 1977). General molecular biol-
ogy techniques were performed according to Sambrook et al.
(1989).
Cells and cell culture
The cell line CV1 originates from African green monkey kidney
and was obtained from ATCC (no. CCL 70). COS cells are derived
from CV1 cells that were transformed by an origin-defective
mutant of SV40, which codes for the wild-type T antigen (Gluz-
man, 1981). COS cells were obtained from ATCC (no. CRL
1650). The cells were propagated in Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum (DMEM-FCS).
Antibodies
The polyclonal antisera against fusion proteins of b -galactosidase
and parts of Ii were described before (Lipp and Dobberstein, 1986;
Wraight et al., 1990; Pieters et al., 1991). Antisera recognizing an
Ii N-terminal portion were raised against a fusion protein con-
taining the N-terminal 73 amino acids (Ii1-73) of Ii and b -galac-
tosidase (anti-IiN); antisera recognizing an Ii C-terminal portion
were raised against a fusion protein containing amino acids 73-
216 of Ii (Ii73-216) and b -galactosidase (anti-IiC); VIC Y1 (Quar-
anta et al., 1984) is a mouse monoclonal antibody that recognizes
an epitope within the N-terminal, cytosolic, amino acids of Ii
(Wraight et al., 1990; Bakke et al., unpublished), and was a kind
gift from Dr W. Knapp, Vienna, Austria. Clonab LN2 (Biotest
AG, FRG) is a mouse monoclonal antibody recognizing an epi-
tope in the C-terminal portion of Ii (within amino acids 157-216;
Wraight et al., 1990). Rabbit anti-human transferrin was purchased
from Boehringer Mannheim Biochemicals. Rabbit polyclonal anti-
serum against the (cation-independent) mannose-6-phosphate
receptor (CI-MPR) (Griffiths et al., 1988) was a gift from Dr
Hoflack, EMBL, Heidelberg, FRG. Rabbit polyclonal antiserum
against human lysosome-associated membrane protein (h-LAMP;
Carlsson et al., 1988) was a kind gift from Dr Fukuda, La Jolla,
CA. USA. Antibodies against neuraminidase from influenza strain
A/Victoria//3/75) were a kind gift from Dr Douglas, NIMR, Mill
Hill, London).
Transient transfection in CV1 and COS cells
CV1 or COS cells were transiently transfected using DEAE-dex-
tran-mediated transfection (Huylebroeck et al., 1988) or by using
the transfection reagent DOTAP (Boehringer Mannheim). Briefly,
80% confluent monolayers of cells were trypsinized and seeded
in 5 cm tissue culture dishes (Falcon) 8-16 hours prior to trans-
fection. Five m g of plasmid DNA was used per dish. For DEAE-
dextran-mediated transfection, the plasmid DNA was dissolved in
1.5 ml of Eagle’s minimal essential medium (MEM) containing
25 mM HEPES (pH 7.2) (MEM-HEPES) and mixed with 1.5 ml
of 1 mg/ml DEAE-dextran (Mr 50,000; Pharmacia) in MEM-
HEPES. After 30 minutes incubation at room temperature, this
mixture was added to the cells and incubated for 60 minutes at
room temperature. The transfection medium was removed, the
cells were washed with DMEM and incubated for 4 hours in
DMEM-FCS containing 0.1 mM chloroquine (Sigma) in 5% CO2
at 37°C. The cells were washed in DMEM-FCS, and incubated in
DMEM-FCS containing 0.1 mM sodium butyrate (Merck). After
12 hours incubation in 10% CO2 at 37°C the cells were washed
and fresh DMEM-FCS was added. For DOTAP-mediated trans-
fection, 5 m g plasmid DNA was dissolved in 100 m l HBS (20 mM
HEPES, pH 7.4, 150 mM NaCl) and mixed with 100 m l 0.3 mg/ml
DOTAP in HBS. After 10 minutes at room temperature, 4 ml
DMEM was added, and cells incubated in this mixture at 10%
CO2 and 37°C. After 4 hours, 1% FCS was added and the cells
were incubated for an additional 8 hours before the transfection
medium was removed and fresh DMEM-FCS was added.
Metabolic labelling
Cells were grown in tissue culture dishes. Prior to labelling the
medium was replaced by methionine-free or methionine- and cys-
teine-free medium. After 40 minutes this medium was replaced
by methionine-free or methionine- and cysteine-free medium con-
taining 0.1 mCi/ml [35S]methionine (Amersham, United King-
dom) or Tran-35S-label (ICN Biomedicals, Irvine, CA, USA).
After 20 minutes, the radioactive medium was removed, the cells
were washed twice in RPMI-FCS containing 2 mM methionine
or 2 mM methionine and 2 mM cysteine and incubated at 37°C
in the same medium.
At the times indicated in the figure legends, the dishes were
placed on ice, washed 3´ with ice-cold PBS and the cells were
lysed in 20 mM Hepes, pH 7.5, containing 100 mM NaCl, 5 mM
MgCl2, 1% Triton X-100 and a cocktail of protease inhibitors con-
sisting of 10 m g/ml each of chymostatin, leupeptin, aprotinin, pep-
statin and 20 m M PMSF. After 15 minutes incubation on ice, the
cell lysates were collected and centrifuged at 13,000 g for 15 min-
utes to remove cell debris.
Cell surface quantification
COS cells were grown in 10 cm dishes and transfected as
described above. After 12 hours, cells were metabolically labelled
for 12 hours using 0.1 mCi/ml Tran-35S-label. The cells were
transferred to ice, washed with DMEM and incubated with anti-
IiC in DMEM for 2 hours. Cells were then washed extensively
with DMEM and PBS, and incubated for 15 minutes with an
extract prepared from cells expressing Ii to block excess antibod-
ies. Cells were then washed 4´ with PBS and PBS containing 5%
FCS, followed by detergent lysis. From the lysates, immunecom-
plexes were either directly purified by the addition of Protein A-
Sepharose beads (to precipitate cell surface Ii or Ii mutant pro-
teins), or after the addition of anti-IiC antiserum (to precipitate
total Ii or Ii mutant molecules). Immunoprecipitation and SDS-
PAGE was carried out as described below.
Internalization
Internalization of anti-IiC antibodies was essentially performed as
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described by Harter and Mellman (1992). Briefly, transfected COS
cells were incubated with 125I-labeled anti-IiC antibodies for two
hours at 4°C. Cells were washed extensively, and incubated in
pre-warmed normal medium at 37°C for the times indicated. Cells
were then cooled on ice and treated twice with 0.5 M acetic acid
in 0.15 M NaCl (pH 2.5) for 5 minutes. Internalization was
expressed as the fraction of antibody initially bound that was resis-
tant to the low pH wash. Alternatively, the amount of anti-IiC
antibodies that remained at the cell surface after the warm up
period was quantified using FITC-conjugated second antibodies
by FACSscan analysis. These two methods revealed quantitatively
equivalent values.
Immunoprecipitation and electrophoresis
Cell lysates from 1´ 106 cells were incubated with antibody at 4°C
for 12 hours, followed by the addition of 40 m l Protein A-
Sepharose (1:1 slurry) and further incubation for 2 hours. The
beads were washed twice with 1 ml of low salt buffer (10 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 0.2% NP-40 and 2 mM EDTA),
twice with 1 ml of high salt buffer (10 mM Tris-HCl, pH 7.5, 500
mM NaCl, 0.2% NP-40 and 2 mM EDTA), and twice with 1 ml
of 10 mM Tris-HCl, pH 7.5. The antigens were eluted from the
Protein A-Sepharose beads by the addition of sample buffer, dena-
tured and subjected to SDS-PAGE (10-15%) according to
Laemmli (1970), fluorography and autoradiography. For quantifi-
cation, gels were exposed to a phosphoimager analysis screen and
analyzed using the software supplied by the manufacturer.
Endoglycosidase digestions
Antigens bound to 20 m l of the Protein A-Sepharose beads (see
above) were incubated with 5 mU endoglycosidase H (Boehringer
Mannheim, Mannheim, FRG) in 100 m l 1 0 mM sodium acetate
(pH 5.5), 9 mM CaCl2, 150 mM NaCl containing protease
inhibitors for 12 hours at 37°C. Thereafter, sample buffer was
added to the beads and proteins were processed as described
above.
Immunofluorescence microscopy
Immunofluorescence labelling was essentially performed as
described by Bakke and Dobberstein (1990). Briefly, viable cells
grown on coverslips were incubated on ice with the appropriate
antibody and a fluorescently labelled second antibody to label anti-
gens on the plasma membrane. Then, the cells were fixed using
3% paraformaldehyde and permeabilized with Triton X-100. To
label intracellular molecules, fixed and permeabilized cells were
labelled using antibodies and fluorescein or Texas Red-conjugated
second antibody as described in the figure legends. Alternatively,
cells were fixed in methanol (4 minutes at - 20°C). After labelling,
the coverslips were mounted in Mowiol (Hoechst, FRG). Exami-
nation was performed using a Zeiss Axiophot fluorescence photo-
microscope equipped with a ´ 40 objective and filters for fluores-
cein or Texas Red, or using a Bio-Rad MRC 600 CSLM.
RESULTS
Characterization of the compartments in which Ii
accumulates when expressed in CV1 cells
Previously it has been shown that in transfected CV1 cells
Ii can be localized in endosomes whereas very little Ii is
found on the plasma membrane (Bakke and Dobberstein,
1990). Ten hours after transfection, Ii was seen in small
vesicles in the perinuclear region (Bakke and Dobberstein,
1990; and Fig. 1A, panel A). After 20 and 30 hours Ii accu-
mulated in large vacuoles in all transfected cells (Fig. 1A,
panels B and C). Accumulation of Ii in these vacuolar struc-
tur s required the presence of amino acid residues 1-11 of
the cytoplasmic tail, as Ii mutants lacking 11 or more
residues from the amino terminus did not accumulate in
these vacuoles but rather in small vesicular structures
throughout the cell (Fig. 1A, panels D-F).
That the accumulation of Ii in large vacuoles is not an
artefact of the expression system is further demonstrated by
the fact that in cells expressing D 1-11Ii vacuoles were never
present, whereas in cells expressing Ii the large vacuoles
could be detected using phase-contrast optics (Fig. 1B).
To identify these large vacuoles and to characterize fur-
ther the site of Ii accumulation we double-labelled CV1
cells 30 hours after transfection with anti-Ii antibodies and
antibodies against several markers for known intracellular
compartments. For the endoplasmic reticulum (ER) we used
a polyclonal antiserum raised against resident proteins of
the rough endoplasmic reticulum (anti-RER antiserum;
Louvard and Warren, 1982). As shown in Fig. 2A, panels
A and B, the vacuoles, which were positive for Ii, were not
labelled with the anti-RER antiserum. Ii also did not colo-
calize with protein disulfide isomerase (PDI; Freedman et
al., 1984), another resident ER protein (Fig. 2A, panels C
and D).
Glycoproteins acquire sialic acid in the trans-Golgi net-
work (TGN). To label molecules that have been modified
in the TGN we used wheat germ agglutinin (WGA) from
Trit cum vulgaris. WGA is a lectin that binds to sialic acid
and therefore labels proteins having reached or passed the
TGN (Virtanen et al., 1980; Lippincott-Schwartz et al.,
1989). As is shown in Fig. 2A, panels E and F, after block-
ing plasma membrane staining by preincubation of intact
cells with unlabelled WGA, the Ii-positive large vacuolar
structures can be labelled with FITC-WGA. This indicates
that proteins resident in these structures have passed
through the TGN.
In most cells the (cation-independent) mannose 6-phos-
phate receptor (CI-MPR) distributes in the TGN and late
endosomes (Griffiths et al., 1988; Geuze et al., 1985; Geuze
et al., 1988). As shown in Fig. 2B, panels A and B, Ii colo-
calized partially with the CI-MPR. 
The Ii-positive vacuoles contained the lysosomal marker
protein LAMP (lysosome-associated membrane protein;
Carlsson et al., 1988) as is shown in Fig. 2B, panels C and
D.
T e large Ii-positive organelles can be reached by endo-
cytic marker proteins. We used the iron-containing protein
transferrin as a marker for endosomes. Iron-transferrin is
internalized as a ligand of the transferrin receptor and trans-
ported to endocytic compartments where the iron is
unloaded (Dautry-Versat et al., 1983). The complex of
transferrin and receptor is then recycled to the cell surface.
Transferrin and its receptor is widely used as a marker for
endocytic compartments (Hopkins, 1983; Lippincot-
Schwartz et al., 1991). CV1 cells expressing Ii were incu-
bated for 2 hours with iron-saturated transferrin, fixed, per-
meabilized and double-labelled for immunofluorescence
using anti-Ii antibodies and antibodies against transferrin.
As is shown in Fig. 3A, the Ii-positive vacuoles were pos-
itive for transferrin.
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The Ii-positive structures were also labelled with Texas
Red-conjugated ovalbumin (OVA-TR) that was given to the
cells for 45 minutes followed by a 45 minute chase in OVA-
TR free medium (Fig. 3B).
Taken together, these results show that Ii in CV1 cells
accumulated in vacuoles that were positive for marker pro-
teins for endosomal and lysosomal compartments.
Ii deletion mutants
It has been shown previously that Ii and an Ii mutant in
which the N-terminal 11 amino acid residues were deleted,
is present in endocytic structures in CV1 cells. Deletion of
15 or more amino acid residues resulted in molecules that
became resident at the plasma membrane (Bakke and Dob-
berstein, 1990). It was proposed that amino acids between
residues 11 and 15 are important for targeting of Ii to endo-
somal compartments. To further characterize sorting infor-
mation in the Ii cytoplasmic tail we made two types of dele-
tions within the cytoplasmic tail (see Fig. 4); residues
between amino acids 11 and 15 were deleted, as were
increasing segments in the membrane proximal region. 
In two constructs (D 12-15Ii and D 13Ii) all four
(E12QLP15) or only one (Q13) residue(s) of the sequence
between residues 11 and 15 were deleted. Three other con-
struct  (D 21-29Ii, D 16-29Ii and D 12-29Ii) contained pro-
gressive deletions from the transmembrane region up to
residue 11, in order to analyze the contribution of the mem-
brane proximal region to the targeting function of the cyto-
plasmic tail.
Recombinant plasmids were transfected into CV1 cells
and expression of the Ii mutants analyzed 20 hours after
transfection. Newly synthesized proteins were metaboli-
cally labelled for 20 minutes using [35S]methionine, the
cells lysed and antigens were immunoprecipitated using
anti-IiC antiserum. Half of the immunoprecipitated mater-
ial was digested with endoglycosidase H (endo H). After
separation by SDS-PAGE and autoradiography in each case
 single major polypeptide of the expected size was
detect d. Densitometric analysis of the autoradiographs
rev aled that all mutant proteins were expressed at equal
levels. After endo H digestion, the molecular masses of Ii
and a l the mutant proteins were each reduced by about 6
kDa, indicative of the removal of two N-linked oligosac-
charide side chains in each case (results not shown). As
glycosylation sites on Ii are present on the luminal, C-ter-
minal portion, this suggests that the Ii mutants have the
same orientation across the membrane as Ii. To investigate
t  a quisition of complex-type carbohydrates on Ii mutant
Fig. 1.(A) Immunofluorescence
analysis of the intracellular location
of Ii (panels A-C) and D 1-11Ii
(panels D-F) in CV1 cells 10 (A, D),
20 (B, E) and 30 (C, F) hours after
transfection. At the different times
cells were fixed in
paraformaldehyde, permeabilized
using Triton X-100 and incubated
with anti-Ii monoclonal antibody
VIC Y1 or LN2. Antigens were
visualized using FITC-conjugated
second antibody. (B) Light
micrograph using phase-contrast
optics of transfected CV1 cells.
Cells were grown on coverslips and
transfected with Ii or D 1-11Ii in
pSV51L. After 30 hours, cells were
analyzed morphologically using
phase-contrast. Cells transfected
with Ii contained large vacuolar
structures (see right panel), whereas
in cells transfected with D 1-11Ii no
large vacuoles could be detected
(left panel).
A
B
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molecules, the above described labeling procedure was
repeated, and the cells were chased for 2 hours in the pres-
ence of cold methionine before lysis. After immunoprecip-
itation of Ii molecules from the lysate and incubation of the
immunoprecipitated material with endo H, the percentage
of endoglycosidase H-resistant molecules was determined.
In all cases, 20-30% of the Ii mutant molecules were endo
H resistant, indicating that the different Ii mutant molecules
were transported at a similar rate.
Cellular localization of Ii mutant proteins
The location of the Ii mutants in transfected CV1 cells was
analyzed by indirect immunofluorescence microscopy.
Plasma membrane molecules were detected by incubation
of cells on ice with rabbit anti-IiC antiserum followed by
Texas Red-conjugated second antibody. To detect intracel-
lular molecules, the same cells were fixed in paraformalde-
hyde, permeabilized with Triton X-100 and labelled with
the monoclonal antibody LN2 followed by FITC-conju-
gated second antibody. LN2 recognizes a C-terminal epi-
tope of Ii that is also recognized by anti-IiC (Wraight et
al., 1990; Bakke and Dobberstein, 1990). Thus, Ii or Ii
mutants localized at the plasma membrane will be labelled
by anti-IiC only, not by LN2 (Bakke and Dobberstein,
1990).
D 12-15Ii, D 13Ii, D 21-29Ii and D 16-29Ii were found
largely in intracellular small vesicular structures through-
out the cell (see Fig. 5A, A-D). In some cells low amounts
of mutant proteins were present at the plasma membrane.
Aft r 30 hours of transfection, these mutant proteins accu-
mulated in large endosomal vacuoles that labelled with the
same marker proteins as the Ii-positive vacuoles (not
shown).
A different phenotype was observed for mutant Ii pro-
Fig. 3. Double labelling of
transfected CV1 cells for Ii and
markers for endocytic
compartments. CV1 cells were
grown on coverslips and
transfected with Ii in pSV51L.
(A) Cells expressing Ii for 30
hours were incubated in medium
containing 50 m g/ml human
transferrin (Tf) for 2 hours. After
fixation and permeabilization
antigens were labelled using rabbit
anti-human transferrin antibody
(anti-Tf) followed by Texas Red-
conjugated second antibody, and
anti-Ii mAb LN2 followed by
FITC-conjugated second antibody.
(B) Cells expressing Ii for 30
hours were incubated in medium
containing 0.5 mg/ml OVA-TR
for 45 minutes (left-hand panel),
followed by a 45 minute chase in
OVA-TR-free medium. After
fixation and permeabilization
antigens were labelled with the
anti-Ii mAb LN2 followed by
FITC-conjugated second antibody
(right-hand panel).
A
B
Fig. 4. Outline of Ii and N-terminal, cytoplasmic amino acid
sequences of the Ii deletion mutants. The construction of these
mutants is described in Materials and Methods. The gray boxes
indicate the transmembrane regions. Note the presence of two
arginine residues in D 16-29Ii and D 12-29Ii that were introduced to
ensure proper membrane insertion and orientation.
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teins lacking amino acid residues 12-29. D 12-29Ii was
expressed in high amounts at the plasma membrane (Fig.
5A, panel E). In addition, this protein was located in a punc-
tate, vesicular staining pattern throughout the cytoplasm
(Fig. 5A, panel F). When the cellular location of D 12-29Ii
was analyzed after different times of transfection, it was
found to accumulate in large vacuolar structures (Fig. 5B,
panels A-C).
Thus, the presence of the first 11 amino acid residues of
the Ii cytoplasmic tail are sufficient to target the Ii mutant
molecules to similar vacuolar structures to those in which
wild type Ii is accumulated.
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Fig. 5. (A) Plasma membrane and
intracellular localization of Ii
mutant proteins in transfected
CV1 cells. CV1 cells were grown
on coverslips and transfected with
the indicated constructs in
pSV51L. After 20 hours, the cells
were incubated on ice with anti-
IiC antiserum and Texas Red-
conjugated second antibody to
label cell surface molecules only.
After fixation with
paraformaldehyde and
permeabilization with Triton X-
100 the intracellular antigens were
labelled using the monoclonal
anti-Ii antibody LN2 and FITC-
conjugated second antibody.
Panels A,C and E show plasma
membrane labelling (Texas Red),
and B, D and F show the same
cells labelled with LN2 (FITC)
after permeabilization. Bar, 20
m m. (B) Intracellular localization
of D 12-29Ii analyzed after 10 (A),
20 (B) and 30 (C) hours of
transfection. At the times indicated
cells were incubated on ice with
anti-IiC antiserum, fixed,
permeabilized, and intracellular
antigens were labelled using LN2
followed by FITC-conjugated
second antibody. Bar, 15 m m.
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B
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Quantification of the cellular location
To quantify the surface expression of Ii and Ii mutant pro-
teins we determined the percentage of cell surface
expression of the different mutant proteins. For this part of
the study, we made use of COS cells, a cell line that is
derived from CV1 cells (Gluzman, 1981). The fraction of
cells expressing mutant proteins was 40-50% for COS cells,
compared to 5-10% for CV1 cells, possibly because COS
cells are transformed with wild-type T antigen (Gluzman,
1981). The cellular locations of Ii and mutant proteins
expressed in COS cells were identical to their location in
CV1 cells. The morphology of COS cells we found to be
less regular than the morphology of CV1 cells. Therefore,
for the immunolocalization studies we used CV1 cells.
COS cells expressing Ii and Ii mutant proteins for 12
hours were metabolically labelled with [35S]methionine and
[35S]cysteine for 12 hours. Immunodetection of cell surface
molecules was carried out by incubating the cells on ice
with anti-IiC antiserum. Excess antibody was quenched by
adding an extract prepared from cells expressing Ii. After
lysis, the lysate was devided into 2 parts; from one, anti-
body-bound surface molecules were recovered by binding
to Protein A-Sepharose (4/5th of the lysate). From the other,
total Ii or mutant Ii molecules were recovered after incu-
bation with anti-IiC antiserum and Protein A-Sepharose
(1/5 h of the lysate). Each immunoprecipitated sample was
incubated in the presence or absence of endoglycosidase H,
and polypeptides were separated by SDS-PAGE and visu-
alized by autoradiography.
Fig. 6A shows the results for Ii and D 1-20Ii. The amount
of Ii present on the cell surface of Ii-transfected cells was
fou d to be very low (Fig. 6A, lanes 1-4). In contrast, a
c nsiderable amount of D 1-20Ii was found at the cell sur-
face of transfected cells (Fig. 6A, lane 5-8).
D 1-20Ii proteins at the cell surface were found to con-
tain carbohydrate side chains sensitive to endo H digestion.
Three distinct bands were found after such treatment (Fig.
6A, lane 8); D 1-20Ii proteins containing no (lower band),
one (middle band) or two complex-type carbohydrates
(upper band). Modification of carbohydrate moieties on
polypeptides from the high-mannose form to the complex
type takes place in the Golgi complex, and therefore is
Fig. 6. Quantification of Ii and Ii mutant molecules present at the plasma membrane of transfected COS cells. COS cells were transfected
with Ii and Ii mutants in pSV51L as indicated. Twelve hours after transfection, cells were metabolically labelled with Tran-35S-label, and
antigens were immunoprecipitated from the cell surface and from total lysates using anti-IiC antiserum as described in Materials and
Methods. (A) Immunoprecipitation of total and cell surface localized Ii or D 1-20Ii molecules from transfected COS cells. One half of the
immunoprecipitated material was treated with endoglycosidase H (Endo H) before SDS-PAGE and autoradiography. Note the presence of
both complex-type (*) and high-mannose (o) carbohydrate forms of D 1-20Ii at the cell surface. (B) Quantification of Ii and Ii mutant
molecules localized at the cell surface. For quantification, gels were exposed to a phosphoimager screen and the percentage of cell surface
immunoprecipitated molecules versus total was determined. Results represent the mean of three independent experiments (± 5% of the
values shown).
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usually taken as a marker for passage through the Golgi
complex (Kornfeld and Kornfeld, 1985). Therefore, part of
the mutant Ii molecules may have bypassed the TGN en
route to the plasma membrane. We cannot, however,
exclude the possibility that incomplete modification of the
carbohydrate side chains may be due to the high expression
of the Ii mutants in COS cells, or their inaccessibility to
the carbohydrate processing enzymes.
To quantify the amount of Ii and Ii mutant proteins at
the cell surface, the above described procedure was repeated
for Ii, D 1-11Ii, D 1-15Ii, D 1-20Ii, D 12-15Ii, D 16-29Ii and
D 12-29Ii. After exposure of the gel to a phosphoimager
screen, the percentage of molecules present at the plasma
membrane relative to the total amount was calculated, and
the result is presented in Fig. 6B. Ii was present in low
amounts at the surface (2% of total). Ii mutants D 1-11Ii,
D 12-15Ii and D 16-29Ii were present in low, but slightly
higher amounts than Ii at the plasma membrane (4-7% of
total). High plasma membrane expression was found for
D 1-15Ii, D 1-20Ii and D 12-29Ii (10-16% of total).
Internalization of Ii and Ii mutant molecules
Targeting of Ii to endosomes may occur directly intracel-
lularly or by internalization from the plasma membrane. As
some of the wild-type Ii and the Ii cytoplasmic deletion
mutants were detected at the plasma membrane (Fig. 6B),
we investigated whether Ii was internalized from the plasma
membrane. Internalization was monitored after binding of
125I-labeled anti-IiC antibodies at 4°C to the surface of
transfected COS cells expressing Ii and mutant Ii molecules
(Fig. 7). Ii was found to be rapidly internalized from the
cell surface, in contrast to D 1-20Ii. The cytoplasmic dele-
tion mutants D 1-11Ii and D 12-29Ii were both internalized
from the cell surface with an efficiency similar to that of
wild-type Ii (Fig. 7).
Identification of a leucine-isoleucine pair as an
endosomal targeting signal in the Ii cytoplasmic
tail
The first 11 amino acid residues of the Ii cytoplasmic tail
are su ficient for Ii localization in endocytic structures (Fig.
5), function as an endocytosis signal (Fig. 7), and are also
responsible for the accumulation of Ii molecules in large
vacuolar structures (Fig. 5B). This sequence contains a
leucine-isoleucine pair at position 7 and 8 that has been
mplicated both in internalization (Letourneur and Klaus-
ner, 1992) and in sorting from the Golgi to endosomes/lyso-
somes (Johnson and Kornfeld, 1992).
To investigate the contribution of the leucine-isoleucine
motif in endosomal targeting of Ii directly, these two amino
acid residues were changed to alanine in the mutant D 12-
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Fig. 7. Internalization of Ii and Ii deletion mutants in transfected
COS cells. COS cells were transfected with Ii and Ii mutants in
pSV51L as indicated. After 20 hours, cells were incubated on ice
with 125I-labelled anti-IiC for 2 hours, washed and incubated at
37°C for the times indicated. At each time point, surface-bound
antibodies were removed by low pH wash. Internalization is
expressed as percentage of initially bound 125I-labelled anti-IiC
present at the cell surface at each time point. Data points represent
determinations in duplicate that differed by less then 10%.
Fig. 8. (A,B) Plasma membrane and intracellular localization of D 12-29IiLI-AA . CV1 cells were grown on coverslips and transfected with
D 12-29IiLI-AA in pSV51L. Plasma membrane (A) and intracellular labeling (B) was performed as described in the legend to Fig. 5. Bar,
20 m m. (C) Internalization of D 12-29Ii and D 12-29IiLI-AA in transfected COS cells (see legend to Fig. 7). Internalization is expressed as
the percentage of anti-IiC antibodies present at the cell surface at each time point as determined using FITC-conjugated second antibody.
Shown is the mean (±10%) of duplicate experiments.
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29Ii. The resulting mutant D 12-29IiLI-AA was transfected
into CV1 cells and the cellular localization was analyzed
30 hours after transfection by indirect immunofluorescence
microscopy. As shown in Fig. 8, panels A and B, this
mutant protein is present in high amounts at the plasma
membrane, and intracellularly its localization is confined to
the Golgi region. No accumulation in intracellular vesicles
or vacuolar structures could be detected. Internalization of
anti-IiC antibodies was monitored after binding at 4°C to
the surface of cells expressing either D 12-29Ii or D 12-
29IiLI-AA . As shown in Fig. 8, panel C, the internalization
of D 12-29IiLI-AA dropped to the same levels as for the D 1-
20Ii mutant molecules. In conclusion, these results show
that the leucine-isoleucine pair at position 7-8 of the Ii cyto-
plasmic tail is essential for internalization from the cell sur-
face and for targeting of Ii molecules to endocytic vacuoles.
Hybrid Ii-neuraminidase (INA)
To investigate whether the Ii cytoplasmic tail is sufficient
for targeting to endosomes, it was fused to the transmem-
brane and luminal portion of the influenza neuraminidase
molecule (NA) (van Rompuy et al., 1982). Neuraminidase
is a type II membrane protein expressed at the surface of
cells infected with influenza virus (Sivasubramanian and
Nayak, 1987). As outlined in Fig. 9A, cDNAs coding for
neuraminidase and for a hybrid Ii-neuraminidase (INA)
molecule, were cloned into the eukaryotic expression vector
pSV51L.
The synthesis and acquisition of compex-type carbohy-
drate side chains of Ii, NA and INA was analyzed in trans-
fected COS cells. Newly synthesized proteins were labelled
24 hours after transfection for 20 minutes using Tran-35S-
label and chased for 1, 2, 3 and 4 hours. Cells were lysed
and proteins were immunoprecipitated with the monoclonal
anti-Ii antibody VIC-Y1 or anti-neuraminidase antibody
NC75. To determine complex-type carbohydrate addition
half of the immunoprecipitated material was digested with
endoglycosidase H. The immunoprecipitated material was
subjected to SDS-PAGE and autoradiography. The results
are presented in Fig. 9B, panels A-C. The percentage of
endoglycosidase H-resistant molecules at each time point
is shown in Fig. 9B, panel D. 
As judged by the resistance to endo H digestion, about
20% of Ii molecules had acquired compex-type carbohy-
drate after 4 hours chase (Fig. 9B, panels A and D). In con-
trast, n arly 80% of NA molecules were converted to the
complex type already after 3 hours chase (Fig. 9B, panels
B and D). For INA about 60% of the molecules were con-
verted to the complex type within 4 hours (Fig. 9B, panels
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INA
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Fig. 9.(A) Outline of Ii, neuraminidase (NA) and the Ii-NA
hybrid molecules INA. The transmembrane regions are indicated
by gray boxes. Glycosylation sites for N-linked carbohydrate side
chains are indicated by asterisks. Sequences of the Ii, NA and INA
cytoplasmic tails are shown in the lower half. (B) Pulse-chase
analysis of newly synthesized invariant chain (Ii), neuraminidase
(NA) and the Ii-NA chimaeric protein INA in COS cells. COS
cells were transfected with Ii, NA or INA. After 20 hours, newly
synthesized proteins were labelled with Tran-35S-label for 20
minutes and chased for the times indicated at the bottom of panel
D. Cells were lysed and proteins immunoprecipitated using anti-Ii
mAb VIC Y1 (panel A), or anti-neuraminidase mAb NC75
(panels B and C). One half of the immunoprecipitated material
was treated with endoglycosidase H before SDS-PAGE and
autoradiography. Asterisks, complex-type; and o, high-mannose
carbohydrate forms. For quantification, the gels were exposed to a
phosphoimager screen and the percentage of endo H-resistant
proteins determined (panel D).
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C and D). As addition of complex-type carbohydrate occurs
in the Golgi we conclude that transport of both NA and
INA from the ER to Golgi compartments was considerably
faster than that of Ii.
Cellular location of neuraminidase and INA
The intracellular location of NA and INA was analyzed by
indirect immunofluorescence. Cells were grown on cover-
slips and transfected with recombinant plasmids encoding
NA or INA. After 20 hours the cells were incubated on ice
with rabbit anti-NA antiserum followed by Texas Red-con-
jugated second antibody to label plasma membrane mole-
cules. After fixation of the cells in paraformaldehyde and
permeabilization with Triton X-100, intracellular molecules
were labelled using anti-NA or anti-Ii monoclonal antibod-
ies and FITC-conjugated second antibody. The results are
J. Pieters, O. Bakke and B. Dobberstein
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Fig. 10. Localization of
neuraminidase (NA) and the
invariant chain-neuraminidase
fusion protein (INA) in CV1
cells. Cells were grown on
coverslips and transfected with
plasmids encoding NA or INA.
(A) Cells expressing NA were
labelled on ice with a mixture of
polyclonal anti-NA antisera
followed by Texas Red-
conjugated second antibody
(plasma membrane, panel A).
After paraformaldehyde fixation
and permeabilization with Triton
X-100 the cells were labelled
using monoclonal anti-NA
antibody NC75, followed by
FITC-conjugated second
antibody (intracellular, panel B).
(B) Cells expressing INA were
labelled on ice with a mixture of
polyclonal anti-neuraminidase
antisera followed by Texas Red-
conjugated second antibody
(plasma membrane, panel A and
C). After paraformaldehyde
fixation and permeabilization
with Triton X-100 the cells were
labelled using monoclonal anti-Ii
(VIC-Y1, panel B) or monoclonal
anti-NA antibody (NC75, panel
D) followed by FITC-conjugated
second antibody.
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depicted in Fig. 10A and B. NA is expressed strongly at
the plasma membrane, and intracellularly is found in the
Golgi area (Fig. 10A, panels A and B). INA, in contrast,
shows a weak plasma membrane expression (Fig. 10B,
panels A and C), and a strong intracellular expression in a
punctate pattern throughout the cytoplasm (Fig. 10B, panels
B and D).
Note that expression of INA did not result in formation
of large vacuolar structures (Fig. 1), even when INA trans-
fected cells were analyzed 30 hours after transfection
(results not shown).
The INA-positive structures contained lysosomal marker
proteins. Fig. 11 shows that INA colocalized with lyso-
some-associated membrane protein (LAMP). We therefore
conclude that INA is located in endosomal structures that
are related to lysosomes.
DISCUSSION
Ii accumulates in large endosomal structures
Ii, when expressed in large amounts in CV1 cells, accu-
mulated in large vacuolar structures. These Ii-positive vac-
uoles were not formed when cells were transfected with the
vector alone; formation of the vacuoles was induced by the
high expression of Ii. The Ii-positive vacuoles contained
marker proteins for the trans-Golgi network, endosomes
and lysosomes. In addition, they could be reached by inter-
nalized transferrin and by Texas Red-coupled ovalbumin.
We conclude that Ii is targeted to and retained in the endo-
cytic pathway, thereby creating large vacuolar structures.
Formation of Ii-positive large vacuoles required the pres-
ence of the N-terminal 11 amino acid residues. Deletion
mutants lacking 11 amino acid residues from the N-termi-
nus were only found in small vesicles even 30 hours after
transfection. In cells expressing Ii mutant proteins that con-
tained only the first 11 amino acid residues of the cyto-
plasmic tail (D 12-29Ii) these mutant proteins accumulated
in large vacuoles. Within the 11 N-terminal amino acid
residues of Ii a leucine-isoleucine pair is found, which could
be part of an endocytosis signal. Such a motif has been
found in the cytoplasmic tail of the T-cell antigen receptor
g and d chains to mediate endocytosis (Letourneur and
Klausner, 1992), and in the cytoplasmic tail of the CI-MPR
to mediate sorting to endosomes in the TGN. When this
leucine-isoleucine pair was changed to alanine-alanine,
accumulation in vacuoles was completely abolished. 
Also in HeLa cells large Ii-positive vacuolar structures
have b en observed after transient expression of Ii and were
proposed to be autophagosomes (Lotteau et al., 1990).
Au ophagic vacuoles have been described to originate from
specialized regions in the endoplasmic reticulum, and to
mature into degradative vacuoles containing lysosomal
marker proteins (Dunn, 1990a,b). Autophagic markers
could be colocalized with endosomal markers, CI-MPR and
lysosomal markers (Tooze et al., 1990; Rabinowitz et al.,
1992). We cannot exclude the possibility that the Ii-posi-
tive large vacuoles are autophagosomes, as was suggested
earlier (Lotteau et al., 1990).
Ii or Ii mutant proteins present at the plasma membrane
were found to contain, besides complex-type, high-mannose
carbohydrate moieties. Complex-type sugar addition may
be incomplete; it may however be possible that part of the
Ii molecules are not transported through the Golgi but
follow an alternative route to endosomes (Lotteau et al.,
1990). 
The chimaeric protein INA, which is almost completely
convert d to the complex-type carbohydrate form was never
fou d to accumulate in large vacuoles. This indicates that
sequences located either within the transmembrane region
and/or the luminal region may contribute to Ii accumula-
tion in vacuoles.
The cytoplasmic tail of Ii contains two endosomal
targeting signals
Analysis of Ii mutants containing deletions in the mem-
brane proximal region revealed two endosomal targeting
signals within the cytoplasmic tail of Ii. Ii mutants con-
aining either amino acid residues 1-11, or 12-29 of the
cytoplasmic tail were found in endosomes, albeit to a dif-
ferent extent. This explains why mutations in one endoso-
mal targeting sequence (as e.g. in D 12-15Ii) did not affect
the final location of Ii, as the second endosomal targeting
sequ nce was still operative.
While the Ii mutant containing residues 1-11 was found
in large vacuolar structures and in high amounts at the
Fig. 11. Double labelling of transfected CV1
cells for INA and LAMP. Cells expressing
INA were grown on coverslips, fixed and
permeabilized. Cells were incubated with
anti-Ii mAb VIC Y1 and rabbit anti-LAMP
antiserum followed by FITC-conjugated goat
anti-mouse and Texas Red-conjugated goat
anti-rabbit second antibody. Bar, 20 m m.
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plasma membrane, the mutant containing residues 12-29
was found in low amounts at the plasma membrane and
intracellularly in small vesicular structures. Within the first
11 amino acid residues of the Ii cytoplasmic tail, a leucine-
isoleucine pair is present at positions 7 and 8. Pairs of
leucine-leucine and leucine-isoleucine have been shown to
function as endosomal/lysosomal targeting signals in the
cytoplasmic tail of the T-cell antigen receptor g and d chains
(Letourneur and Klausner, 1992) and the cytoplasmic tail
of the CI-MPR (Johnson and Kornfeld, 1992). We demon-
strated that the mutation of this leucine-isoleucine pair to
alanine-alanine completely abolished endosomal targeting.
Thus, the Ii cytoplasmic tail contains two independent endo-
somal targeting signals, one of which is located within
residues 12-29, the other consisting of a leucine-isoleucine
motif.
Ii molecules containing both or one of the two endoso-
mal targeting sequences were rapidly internalized from the
cell surface. Thus, at least part of the Ii molecules reached
the endosomes after transport to and internalization from
the plasma membrane. It remains to be established, how-
ever, whether or not internalization from the plasma mem-
brane is the major route to endosomes. The low steady-state
levels of Ii molecules at the cell surface suggests that the
cell surface is not a resident intermediate for transport to
endosomes. It is conceivable that an equilibrium may exist
between the endosomal pool of Ii molecules and the plasma
membrane pool and that molecules that arrive at the plasma
membrane will be internalized when they contain either one
or both of the endosomal targeting sequences. This would
however mean that the same sequences that function as
intracellular sorting signals also function as internalization
signals. In fact, this has been shown to be the case for the
leucine-leucine motif: when present in the Tac antigen, it
functions as an internalization signal (Letourneur and
Klausner, 1992), and when present in the cytoplasmic tail
of the CI-MPR, it functions in sorting from the TGN to
endocytic compartments (Johnson and Kornfeld, 1992).
Tyrosine-containing signals in the cytoplasmic tail of the
CI-MPR and a tyrosine-glycine-containing signal in the tail
of lgp A also serve alternative routes; plasma membrane
internalization and intracellular targeting to endosomes
(Johnson and Kornfeld, 1992; Harter and Mellman, 1992).
The identification of the leucine-isoleucine motif as an
endosomal targeting signal in the cytoplasmic tail of Ii fur-
thermore explains the results obtained by Nillson et al.,
(1991). These investigators found that the Ii cytoplasmic
tail could be exchanged with that of galactosyltransferase
without altering the endosomal location of this chimaeric
molecule. In fact, a leucine-leucine pair is present at posi-
tions 6 and 7 of the galactosyltransferase cytoplasmic tail
(Masri et al., 1988), which might be responsible, in the
absence of the galactosyltransferase transmembrane region,
for targeting to endosomes.
The Ii cytoplasmic tail is sufficient for targeting a
passenger molecule to endosomes
The Ii cytoplasmic tail was found to be sufficient to target
a fusion protein with neuraminidase (NA) as passenger
(INA) to endocytic compartments. Only low amounts of
INA were found at the plasma membrane. The endocytic
INA-positive structures were identified as lysosome-related
compartments as they were labelled with antibodies to lyso-
some-associated membrane protein (LAMP). NA, in con-
trast, was mainly located at the plasma membrane and intra-
cellularly confined to the Golgi region.
A umber of differences existed however, between local-
ization and transport of Ii and INA. First, while Ii induced
and was found in large vacuolar endosomes, INA
expression did not induce these structures. Second, in con-
trast to Ii, carbohydrate moieties on INA molecules were
almost completely modified to the complex type, indicat-
in  that these molecules are readily transported through the
Golgi c mplex. Third, INA molecules were far more stable
than Ii wild type or Ii mutant molecules. 
Thus, the Ii cytoplasmic tail does not contain all the infor-
mation for retention in the same endosomal location of Ii.
As INA only contains the cytoplasmic tail of Ii, the trans-
me brane and/or luminal domain of Ii must also contribute
to the correct endosomal location of Ii. The difference in
l calization between INA and Ii may be due to the pres-
nce f a retention sequence in the Ii transmembrane and/or
luminal domain. 
Taken together, the results we present here show that Ii
con ains two independent targeting signals for the endocytic
pathway in its cytoplasmic tail. One of the proposed func-
tions of Ii is to target MHC class II molecules to endocytic
compartments where they can combine with antigenic pep-
tides. The complexity of signals that regulate Ii transport
to and retention in the endosomal system may be required
to ensure the versatility of class II molecules, maximizing
their exposure to exogenous antigens, as was suggested by
Brodsky (1992). 
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